Skip to main content

Table 3 Tolerance time at LAST interview by patients’ characteristics (n = 167)a

From: Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer

Variable

Category

Tolerance time at LAST interview (n = 167)a

P-value

No time period(n = 23)

n (%)

Months(n = 84)

n (%)

Years(n = 60)

n (%)

Age group (years)

≤ 60 years

5 (21.7)

16 (19.0)

17 (28.3)

0.5219

61–70 years

7 (30.4)

33 (39.3)

24 (40.0)

> 70 years

11 (47.8)

35 (41.7)

19 (31.7)

Gender

Male

14 (60.9)

53 (63.1)

30 (50.0)

0.2794

Female

9 (39.1)

31 (36.9)

30 (50.0)

Race

White or Caucasian

21 (91.4)

81 (96.4)

58 (96.6)

0.6112**

Black/African-American

1 (4.4)

1 (1.2)

1 (1.7)

Other

1 (4.4)

2 (2.4)

1 (1.7)

Education

Less than high school or high school diploma or GED degree

15 (65.2)

47 (58.0)

27 (45.8)

0.1932

Some college or bachelor’s or higher degree

8 (34.8)

34 (42.0)

32 (54.2)

Employment

Working

7 (30.4)

25 (29.8)

15 (25.0)

0.7939

Not working

16 (69.6)

59 (70.2)

45 (75.0)

Marital status

Married

12 (52.2)

63 (75.0)

38 (63.3)

0.0780

Not married

11 (47.8)

21 (25.0)

22 (36.7)

Income

Annual income $45,000 or more

6 (42.9)

32 (50.8)

16 (40.0)

0.5443

Annual income less than $45,000

8 (57.1)

31 (49.2)

24 (60.0)

Primary method of payment

Private insurance

8 (34.8)

31 (36.9)

22 (36.7)

0.6061

Medicare

13 (56.5)

37 (44.1)

24 (40.0)

Medicaid

0 (0.0)

9 (10.7)

9 (15.0)

Others

2 (8.7)

7 (8.3)

5 (8.3)

Urban/Rural

Urban

15 (65.2)

59 (70.2)

40 (66.7)

0.8520

Rural

8 (34.8)

25 (29.8)

20 (33.3)

  1. **Uses Fisher’s Exact Test
  2. aExcludes cases where values were not reported (n = 1)